Chronic Respiratory Disease Participant Engagement
Official title: Engagement Study to Establish a Clinical Baseline for Adult Participants With Chronic Respiratory Diseases and Familiarise Them With the Clinical Trials Unit Environment for Future Clinical Trial Participation
Run by Richmond Pharmacology Limited · NCT07924462 · Data updated 2026-11-12
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Richmond Pharmacology Limited Industry-sponsored |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | November 2026 |
| Main results expected | August 1, 2027 |
| Study ends | August 1, 2027 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT07924462 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older with or suspected of having a chronic respiratory disease such as AATD, COPD, asthma, bronchiectasis, or ILD.
✕Probably not a fit
Participants may not directly benefit from health improvements during this short engagement study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study invites adults with or suspected of having a chronic respiratory condition to spend about five weeks familiarizing themselves with a clinical trials unit. Participants attend two visits: an in-person engagement visit for facility orientation and routine health assessments, followed by a 3-week plus/minus window for a follow-up with a study doctor. Procedures may include medical history review, vital signs, lung function tests, blood tests, ECG, liver assessment, questionnaires on symptoms and quality of life, and possible genetic testing if clinically appropriate. No investigational drugs are given, and the goal is to inform better design of future patient-centered trials.
Why it matters
Potential benefit: Possible improvement in future trial experience and study design for participants with chronic respiratory diseases.
How similar studies have gone: Prior patient-engagement studies in respiratory research have helped tailor trial designs, though this exact format is relatively early-stage.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female participants aged ≥ 18 years at the date of signing the PIS/ICF. 2. Ability to provide written, personally signed, and dated informed consent in accordance with International Council for Harmonisation (ICH) Good Clinical Practice (GCP) Guidelines E6 (R3) (2025) and applicable regulations, before any study-specific procedures are performed. 3. Diagnosis with or suspicion of chronic respiratory disease including but not limited to: AATD, COPD, Asthma, Bronchiectasis, ILD and any other chronic respiratory diseases considered appropriate by the Investigator and Sponsor Exclusion Criteria: 1. Unwilling or unable to comply with the protocol-defined study assessments. 2. Any other significant disease or disorder that, in the opinion of the Principal Investigator (PI) or Sponsor, may either place the participant at risk from participation, or influence the clinical baseline
Where it's running
-
Richmond Pharmacology Limited
London, United Kingdom Recruiting
Study contacts
- Study coordinator: James Rickard, MPharm
- Email: jrickard@richmondresearchinstitute.org
- Phone: +44 (0) 20 7042 5800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Breathlessness in respiratory diseases: who feels it and why
This study tests how physiology, psychology, function, and breathing patterns relate to breathlessness in people with respiratory conditions compared with healthy controls.
-
Understanding the impact of multimorbidity on chronic airway diseases
This study looks at how having multiple health issues affects people with chronic lung diseases like COPD, asthma, or bronchiectasis to help improve their care and treatment.
-
Registry for patients with chronic airway diseases
This study is gathering information from people with chronic airway diseases like COPD and asthma to better understand their conditions and find ways to improve their care.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
Breztri real-world safety and effectiveness in Korean patients with COPD or asthma
This post-marketing study tests Breztri in real-world Korean patients with COPD or asthma to see how safe it is and how well it works when used as usual care.
-
Effects of Wood Smoke on Lung Health in Adults
This study tests how different levels of woodsmoke exposure affect lung function and inflammatory responses in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.